𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mucopolysaccharidosis type IIID: 12 new patients and 15 novel mutations

✍ Scribed by Marlies J. Valstar; Aida M. Bertoli-Avella; Marja W. Wessels; George J.G. Ruijter; Bianca de Graaf; Renske Olmer; Peter Elfferich; Sanne Neijs; Roxana Kariminejad; Fatih Suheyl Ezgü; Aysegul Tokatli; Barbara Czartoryska; Ad N. Bosschaart; Feikje van den Bos-Terpstra; Hugues Puissant; Friederike Bürger; Heymut Omran; D. Eckert; Mirella Filocamo; Emil Simeonov; Patrick J. Willems; Ron A. Wevers; Martinus F. Niermeijer; Dicky J.J. Halley; Ben J.H.M. Poorthuis; Otto P. van Diggelen


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
187 KB
Volume
31
Category
Article
ISSN
1059-7794

No coin nor oath required. For personal study only.

✦ Synopsis


Mucopolysaccharidosis III D (Sanfilippo disease type D, MPS IIID) is a rare autosomal recessive lysosomal storage disorder previously described in only 20 patients. MPS IIID is caused by a deficiency of N-acetylglucosamine-6-sulphate sulphatase (GNS), one of the enzymes required for the degradation of heparan sulphate. So far only seven mutations in the GNS gene have been reported. The clinical phenotype of 12 new MPS IIID patients from 10 families was studied. Mutation analysis of GNS was performed in 16 patients (14 index cases). Clinical signs and symptoms of the MPS IIID patients appeared to be similar to previously described patients with MPS III. Early development was normal with onset of behavioral problems around the age of 4 years, followed by developmental stagnation, deterioration of verbal communication and subsequent deterioration of motor functions. Sequence analysis of the coding regions of the gene encoding GNS (GNS) resulted in the identification of 15 novel mutations: 3 missense mutations, 1 nonsense mutation, 4 splice site mutations, 3 frame shift mutations, 3 large deletions and 1 in-frame small deletion. They include the first missense mutations and a relatively high proportion of large rearrangements, which warrants the inclusion of quantitative techniques in routine mutation screening of the GNS gene.


📜 SIMILAR VOLUMES


Two New Nonsense mutations (Q80X; Q389X)
✍ Romeo Carrozzo; Rossana Tonlorenzi; Fabio Corsolini; Rosanna Gatti 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 192 KB

More than 100 mutations of the HPRT gene have been described related to Lesch-Nyhan syndrome in complete lack of enzyme activity, or KelleySeegmiller syndrome in partial enzyme deficiency. We examined (modified according to genomic DNA from an 11-year-old boy, S.Z., with -1% HPRT activity, who had

Identification of 9 novel IDS gene mutat
✍ Stanislav L. Karsten; Elena Voskoboeva; Britt-Marie Carlberg; Wim J. Kleijer; T 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 2 views

Hunter syndrome is an X-linked lysosomal storage disorder caused by a deficiency of the lysosomal enzyme iduronate-2-sulfatase (IDS). The IDS deficiency can be caused by several different types of mutations in the IDS gene. We have performed a molecular and mutation analysis of a total of 19 unrelat

Molecular analysis of 30 mucopolysacchar
✍ N. Venturi; A. Rovelli; R. Parini; F. Menni; F. Brambillasca; F. Bertagnolio; G. 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 176 KB

Mucopolysaccharidosis type I (MPS-I orMPS1) is an autosomal recessive condition characterized by a broad range of clinical symptoms. Molecular diagnosis of MPS-I is important for analyzing genotype-phenotype correlation and for selecting patients for innovative therapies. In this study we analyzed 3

Molecular analysis of 40 Italian patient
✍ Mirella Filocamo; Gloria Bonuccelli; Fabio Corsolini; Raffaella Mazzotti; Robert 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 34 KB

Mucopolysaccharidosis type II (MPS2, or Hunter syndrome), rare X-linked lysosomal storage disorder, results from deleterious mutations in the iduronate-2-sulfatase (IDS) gene. We report here the mutational analysis of a total of 40 unrelated Italian MPS II patients ranging from mild to severe phenot